Literature DB >> 2166039

Differences in targeting and secretion of cathepsins B and L by BALB/3T3 fibroblasts and Moloney murine sarcoma virus-transformed BALB/3T3 fibroblasts.

C Achkar1, Q M Gong, A Frankfater, A S Bajkowski.   

Abstract

BALB/3T3 fibroblasts (3T3) were observed to secrete latent, pepsin-activatable forms of cathepsin B and cathepsin L as well as an active form of beta-glucuronidase when cultured in the absence of serum. The secretion of these proteins was stimulated by the cation ionophore monensin: cathepsin B, 4.3-fold; cathepsin L, 7.2-fold; and beta-glucuronidase, 3.1-fold. These increases were accompanied by a 50% decline in cellular levels of the active forms of these enzymes and by the cellular accumulation of latent forms of cathepsin B and cathepsin L. Latent forms of beta-glucuronidase were not detected. In contrast, Moloney murine sarcoma virus-transformed BALB/3T3 fibroblasts (MMSV) secreted greatly increased amounts of latent cathepsin B (17-fold) and latent cathepsin L (27-fold), and moderately increased amounts of active beta-glucuronidase (2-fold) in a manner which was not further increased by monensin. The increased monensin-insensitive secretion of these lysosomal enzymes by MMSV cells may be due to a transformation-induced decrease in mannose 6-phosphate receptors. Thus, 3T3 cells bound the neoglycoconjugate pentamannosyl 6-phosphate-bovine serum albumin at 4 degrees C in a pentamannosyl 6 phosphate and mannose 6-phosphate-inhibitable manner, whereas MMSV cells showed no measurable cell surface mannose 6-phosphate receptor binding activity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2166039

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Proteolytic processing and glycosylation of cathepsin B. The role of the primary structure of the latent precursor and of the carbohydrate moiety for cell-type-specific molecular forms of the enzyme.

Authors:  L Mach; K Stüwe; A Hagen; C Ballaun; J Glössl
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

2.  Effect of carbohydrate position on lysosomal transport of procathepsin L.

Authors:  R G Lingeman; D S Joy; M A Sherman; S E Kane
Journal:  Mol Biol Cell       Date:  1998-05       Impact factor: 4.138

3.  Epidermal growth factor-dependent phosphorylation of the GGA3 adaptor protein regulates its recruitment to membranes.

Authors:  Satoshi Kametaka; Rafael Mattera; Juan S Bonifacino
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

Review 4.  Cathepsin B and its endogenous inhibitors: the role in tumor malignancy.

Authors:  B F Sloane; K Moin; E Krepela; J Rozhin
Journal:  Cancer Metastasis Rev       Date:  1990-12       Impact factor: 9.264

5.  The cytoplasmic domain of proEGF negatively regulates motility and elastinolytic activity in thyroid carcinoma cells.

Authors:  Aleksandra Glogowska; Janette Pyka; Astrid Kehlen; Marek Los; Paul Perumal; Ekkehard Weber; Sheue-yann Cheng; Cuong Hoang-Vu; Thomas Klonisch
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

6.  Endocytosis provides a major alternative pathway for lysosomal biogenesis in kidney proximal tubular cells.

Authors:  Rikke Nielsen; Pierre J Courtoy; Christian Jacobsen; Geneviève Dom; Wânia Rezende Lima; Michel Jadot; Thomas E Willnow; Olivier Devuyst; Erik I Christensen
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-16       Impact factor: 11.205

7.  Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages.

Authors:  V Y Reddy; Q Y Zhang; S J Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

8.  Correct processing of the kiwifruit protease actinidin in transgenic tobacco requires the presence of the C-terminal propeptide.

Authors:  W Paul; J Amiss; R Try; U Praekelt; R Scott; H Smith
Journal:  Plant Physiol       Date:  1995-05       Impact factor: 8.340

Review 9.  Autophagy and other vacuolar protein degradation mechanisms.

Authors:  P O Seglen; P Bohley
Journal:  Experientia       Date:  1992-02-15

Review 10.  Biological and clinical characterization of paclitaxel poliglumex (PPX, CT-2103), a macromolecular polymer-drug conjugate.

Authors:  Stewart D Chipman; Fred B Oldham; Gabriella Pezzoni; Jack W Singer
Journal:  Int J Nanomedicine       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.